Proxy advisers Glass Lewis and ISS are both recommending that shareholders approve the 3.15bn revised takeover bid for UDG Healthcare by US private equity firm Clayton Dubilier and Rice (CD&R).
The move by the two groups, which advise institutional shareholders…

Click here to view the original article.